Stock With Great Potential
Analyst says this stock could make quick strides with its unbelievable assets.
Learn more

LABP Insider Trading (Landos Biopharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,949,606.77

Landos Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Landos Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Landos Biopharma Share Price & Price History

Current Price: $0.70
Price Change: Price Increase of +0.0598 (9.34%)
As of 05/17/2022 02:52 PM ET

This chart shows the closing price history over time for LABP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How the Pros Choose Their Stocks
Grab your seat at our free, LIVE, masterclass for traders.

It’s your chance to learn how to pick the right stocks and find the market bottom.

We’ll reveal 3 Tips for dodging volatility and a few under-the-radar stocks we believe have significant potential in the long run.
Click here now to register.

Landos Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021Josep Bassaganya-RieraMajor ShareholderSell33,194$4.75$157,671.50View SEC Filing Icon  
12/17/2021Josep Bassaganya-RieraMajor ShareholderSell36,000$4.84$174,240.00View SEC Filing Icon  
12/15/2021Josep Bassaganya-RieraMajor ShareholderSell43,000$5.02$215,860.00View SEC Filing Icon  
12/13/2021Josep Bassaganya-RieraMajor ShareholderSell40,000$5.37$214,800.00View SEC Filing Icon  
12/10/2021Josep Bassaganya-RieraMajor ShareholderSell40,000$5.77$230,800.00View SEC Filing Icon  
12/8/2021Josep Bassaganya-RieraMajor ShareholderSell25,530$6.65$169,774.50View SEC Filing Icon  
12/6/2021Josep Bassaganya-RieraMajor ShareholderSell36,000$6.17$222,120.00View SEC Filing Icon  
12/3/2021Josep Bassaganya-RieraMajor ShareholderSell36,000$6.15$221,400.00View SEC Filing Icon  
12/1/2021Josep Bassaganya-RieraMajor ShareholderSell32,237$7.01$225,981.37View SEC Filing Icon  
11/29/2021Josep Bassaganya-RieraMajor ShareholderSell15,430$7.58$116,959.40View SEC Filing Icon  
2/8/2021Perceptive Advisors LlcDirectorBuy1,250,000$16.00$20,000,000.00View SEC Filing Icon  
2/5/2021Konstantin PoukalovDirectorBuy27,453$11.14$305,826.42View SEC Filing Icon  
2/4/2021Rtw Investments, LpMajor ShareholderBuy625,000$16.00$10,000,000.00View SEC Filing Icon  
See Full Table
Analysts Favor Stock Like This
This little-known stock shows signs of unprecedented potential under founder & discovery minded CEO.
Click here for the full details.

SEC Filings (Institutional Ownership Changes) for Landos Biopharma (NASDAQ:LABP)

66.53% of Landos Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LABP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Landos Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC340,500$0.50M0.0%+99.0%0.846%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.159,001$0.23M0.0%-47.8%0.395%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.520,308$0.77M0.0%+10.6%1.293%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC105,208$0.51M0.0%N/A0.262%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.470,428$2.26M0.0%+101.4%1.173%Search for SEC Filing on Google Icon
2/19/2022Walleye Trading LLC43,279$0.21M0.0%N/A0.108%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.17,568$84K0.0%N/A0.044%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.17,568$84K0.0%N/A0.044%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC171,100$0.82M0.0%+1,469.7%0.426%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.299,616$1.44M0.0%-3.3%0.747%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC8,274$39K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE31,225$0.15M0.0%+2,001.3%0.078%Search for SEC Filing on Google Icon
2/3/2022OUP Management Co. LLC1,827,478$8.77M4.0%N/A4.555%Search for SEC Filing on Google Icon
11/19/2021American International Group Inc.2,563$37K0.0%-29.2%0.006%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System2,530$37K0.0%-71.8%0.006%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley1,743$26K0.0%-74.8%0.004%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC112,933$1.65M0.0%-11.4%0.282%Search for SEC Filing on Google Icon
11/12/2021Botty Investors LLC128,750$1.88M0.6%+4.9%0.321%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.233,616$3.41M0.0%-20.6%0.582%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG2,693$39K0.0%-30.0%0.007%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.18,831$0.28M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund2,756$40K0.0%-62.5%0.007%Search for SEC Filing on Google Icon
11/2/2021Allworth Financial LP5,286$77K0.0%N/A0.013%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio11,400$0.17M0.0%+660.0%0.028%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley6,912$81K0.0%+1,337.0%0.017%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN9,526$0.11M0.0%+382.6%0.024%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP899,106$10.39M0.9%+22.5%2.241%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE11,223$0.13M0.0%-43.7%0.028%Search for SEC Filing on Google Icon
8/16/2021Tudor Investment Corp Et Al17,793$0.21M0.0%-71.3%0.044%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley6,912$81K0.0%+1,337.0%0.017%Search for SEC Filing on Google Icon
8/16/2021State Street Corp92,367$1.07M0.0%+88.1%0.230%Search for SEC Filing on Google Icon
8/13/2021Botty Investors LLC122,781$1.42M0.5%+26.0%0.306%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC127,518$1.47M0.0%+15.3%0.318%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.305,185$3.52M0.0%+61.9%0.761%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp14,029$0.16M0.0%+37.8%0.035%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.294,043$3.40M0.0%+14.7%0.733%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP734,000$7.07M0.7%N/A1.830%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC15,361$0.15M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/18/2021Zimmer Partners LP90,100$0.87M0.0%N/A0.225%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al61,899$0.60M0.0%N/A0.154%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC681,000$6.56M0.1%N/A1.697%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP50,000$0.48M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/18/2021Old Well Partners LLC18,316$0.18M0.1%N/A0.046%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System9,518$92K0.0%N/A0.024%Search for SEC Filing on Google Icon
5/17/2021Deerfield Management Company L.P. Series C450,000$4.33M0.1%N/A1.122%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC17,960,839$159.69M2.0%N/A44.770%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP213,335$2.05M0.0%N/A0.532%Search for SEC Filing on Google Icon
5/17/2021Caas Capital Management LP40,000$0.39M0.0%N/A0.100%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC10,219$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.70,000$0.67M0.1%N/A0.174%Search for SEC Filing on Google Icon
5/14/2021Laurion Capital Management LP10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/14/2021RTW Investments LP4,275,722$38.33M0.6%N/A10.658%Search for SEC Filing on Google Icon
5/14/2021Monashee Investment Management LLC91,309$0.88M0.1%N/A0.228%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp10,182$98K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/13/2021Botty Investors LLC97,477$0.94M0.3%N/A0.243%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp74,359$0.72M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC110,559$1.06M0.0%N/A0.276%Search for SEC Filing on Google Icon
5/12/2021Ensign Peak Advisors Inc125,000$1.20M0.0%N/A0.312%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.375,021$3.61M0.0%N/A0.935%Search for SEC Filing on Google Icon
5/11/2021Teacher Retirement System of Texas10,000$96K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund7,300$70K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.256,290$2.47M0.0%N/A0.639%Search for SEC Filing on Google Icon
5/7/2021American International Group Inc.3,677$35K0.0%N/A0.009%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Landos Biopharma logo
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therapeutic candidate that targets LANCL2 agonist for the treatment of systemic lupus erythematosus and rheumatoid arthritis (RA). Its preclinical candidates in development include LABP-66 is an oral and small molecule NOD-like pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA; LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; and LABP-111, an oral and small molecule LANCL2 pathway agonist for the treatment of nonalcoholic steatohepatitis and type 1 diabetes. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Read More on Landos Biopharma

Today's Range

Now: $0.70
Low: $0.67
High: $0.71

50 Day Range

MA: $1.27
Low: $0.63
High: $1.83

52 Week Range

Now: $0.70
Low: $0.61
High: $16.17

Volume

47 shs

Average Volume

130,701 shs

Market Capitalization

$28.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Landos Biopharma?

Landos Biopharma's top insider investors include:
  1. Josep Bassaganya-Riera (Major Shareholder)
  2. Konstantin Poukalov (Director)
  3. Perceptive Advisors Llc (Director)
  4. Rtw Investments, Lp (Major Shareholder)
Learn More about top insider investors at Landos Biopharma.

Who are the major institutional investors of Landos Biopharma?

Landos Biopharma's top institutional investors include:
  1. BlackRock Inc. — 1.29%
  2. Renaissance Technologies LLC — 0.85%
  3. Vanguard Group Inc. — 0.39%
Learn More about top institutional investors of Landos Biopharma stock.

Which institutional investors are selling Landos Biopharma stock?

During the last quarter, LABP stock was sold by these institutional investors:
  1. Vanguard Group Inc.

Which institutional investors are buying Landos Biopharma stock?

Within the previous quarter, LABP stock was purchased by institutional investors including:
  1. Renaissance Technologies LLC
  2. BlackRock Inc.
In the previous year, these company insiders have bought Landos Biopharma stock:
  1. Josep Bassaganya-Riera (Major Shareholder)
  2. Konstantin Poukalov (Director)
  3. Perceptive Advisors Llc (Director)
Learn More investors buying Landos Biopharma stock.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.